Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell communications.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
25 05 2021
Historique:
received: 15 07 2020
revised: 05 03 2021
accepted: 23 04 2021
entrez: 26 5 2021
pubmed: 27 5 2021
medline: 11 2 2022
Statut: ppublish

Résumé

Communication between biological components is critical for homeostasis maintenance among the convergence of complicated bio-signals. For therapeutic nanoparticles (NPs), the general lack of effective communication mechanisms with the external cellular environment causes loss of homeostasis, resulting in deprived autonomy, severe macrophage-mediated clearance, and limited tumor accumulation. Here, we develop a multistage signal-interactive system on porous silicon particles through integrating the Self-peptide and Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide into a hierarchical chimeric signaling interface with "don't eat me" and "eat me" signals. This biochemical transceiver can act as both the signal receiver for amantadine to achieve NP transformation and signal conversion as well as the signal source to present different signals sequentially by reversible self-mimicking. Compared with the non-interactive controls, these signal-interactive NPs loaded with AS1411 and tanespimycin (17-AAG) as anticancer drugs improve tumor targeting 2.8-fold and tumor suppression 6.5-fold and showed only 51% accumulation in the liver with restricted hepatic injury.

Identifiants

pubmed: 34038723
pii: S2211-1247(21)00470-8
doi: 10.1016/j.celrep.2021.109131
pmc: PMC8170549
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109131

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Annu Rev Biophys Biomol Struct. 1998;27:59-75
pubmed: 9646862
ACS Nano. 2010 Jun 22;4(6):3023-32
pubmed: 20509673
Nat Commun. 2018 Oct 31;9(1):4548
pubmed: 30382085
J Drug Target. 2009 Aug;17(7):524-32
pubmed: 19530902
Nat Commun. 2017 Oct 3;8(1):777
pubmed: 28974673
Biopolymers. 2015 Mar;104(2):65-72
pubmed: 25471538
Nat Rev Drug Discov. 2016 Aug;15(8):533-50
pubmed: 27050677
Cell. 2011 Dec 23;147(7):1589-600
pubmed: 22196733
Adv Mater. 2018 Jun;30(24):e1703740
pubmed: 29534311
Exp Biol Med (Maywood). 2017 Jul;242(13):1309-1317
pubmed: 28580796
Chem Commun (Camb). 2013 May 7;49(35):3649-51
pubmed: 23531995
Angew Chem Int Ed Engl. 2014 May 12;53(20):5093-6
pubmed: 24700480
Nat Nanotechnol. 2013 Feb;8(2):137-43
pubmed: 23334168
Nat Nanotechnol. 2007 Dec;2(12):751-60
pubmed: 18654426
ACS Appl Mater Interfaces. 2017 Mar 22;9(11):10034-10046
pubmed: 28248078
Acc Chem Res. 2014 Jul 15;47(7):2017-25
pubmed: 24873201
Nanoscale. 2016 Oct 20;8(41):17794-17800
pubmed: 27722485
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70
pubmed: 18809927
Nat Biotechnol. 2015 Sep;33(9):941-51
pubmed: 26348965
Sci Rep. 2017 Sep 5;7(1):10542
pubmed: 28874846
Autophagy. 2019 Jan;15(1):4-33
pubmed: 30160607
Chem Soc Rev. 2016 May 3;45(9):2440-57
pubmed: 26862602
Naturwissenschaften. 2013 Jan;100(1):3-19
pubmed: 23128987
J Chem Inf Model. 2013 Jul 22;53(7):1689-99
pubmed: 23800267
Biomaterials. 2011 Jan;32(1):152-61
pubmed: 20889205
Pharm Res. 2009 Oct;26(10):2270-9
pubmed: 19633820
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Nat Commun. 2018 Apr 12;9(1):1410
pubmed: 29650952
Nat Rev Cancer. 2017 Jan;17(1):20-37
pubmed: 27834398
Chem Soc Rev. 2017 Oct 16;46(20):6379-6419
pubmed: 28930330
Nano Today. 2015 Aug;10(4):487-510
pubmed: 26640510
Nano Today. 2017 Aug;15:8-10
pubmed: 29399037
Cell Commun Signal. 2003 Oct 27;1(1):3
pubmed: 14613520
Nanomedicine (Lond). 2016 Jan;11(1):81-100
pubmed: 26653875
Nat Mater. 2016 Nov;15(11):1212-1221
pubmed: 27525571
Science. 2013 Feb 22;339(6122):971-5
pubmed: 23430657
Nano Lett. 2010 Jan;10(1):250-4
pubmed: 19904979
Adv Mater. 2019 Sep;31(39):e1901778
pubmed: 31328844
Angew Chem Int Ed Engl. 2006 Aug 18;45(33):5465-8
pubmed: 16856195
Beilstein J Nanotechnol. 2014 Sep 24;5:1625-36
pubmed: 25383275
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3473-80
pubmed: 21317359
Carbohydr Polym. 2015 Nov 5;132:205-13
pubmed: 26256342
Carbohydr Res. 2014 Dec 5;400:19-25
pubmed: 25457606
Chem Sci. 2018 Mar 5;9(14):3563-3569
pubmed: 29780488
Adv Mater. 2014 May 28;26(20):3310-4
pubmed: 24677290
ACS Cent Sci. 2018 Aug 22;4(8):952-959
pubmed: 30159392
Chem Soc Rev. 2020 Apr 27;49(8):2273-2290
pubmed: 32215407
Chem Soc Rev. 2011 May;40(5):2254-66
pubmed: 21344115
Cancer Discov. 2013 Apr;3(4):388-98
pubmed: 23550147
Nat Mater. 2012 May 27;11(7):642-9
pubmed: 22635042
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):2060-2065
pubmed: 28167778
Chem Soc Rev. 2017 Jul 17;46(14):4218-4244
pubmed: 28585944
Biochemistry. 1987 Nov 3;26(22):6896-900
pubmed: 2962631
J Comput Aided Mol Des. 2015 May;29(5):451-70
pubmed: 25752764
J Control Release. 2005 Jul 20;105(3):305-17
pubmed: 15908032
Spectrochim Acta A Mol Biomol Spectrosc. 2008 Nov 1;71(1):125-32
pubmed: 18243779

Auteurs

Feng Zhang (F)

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland; Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, P.R. China.

Yiran Zhang (Y)

Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, P.R. China.

Li Kong (L)

Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, P.R. China; Leiden Institute of Chemistry, Leiden University, P.O. Box 9052, 2300 RA Leiden, the Netherlands.

Huanhuan Luo (H)

Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, P.R. China.

Yuezhou Zhang (Y)

Xían Institute of Flexible Electronics & Xían Institute of Biomedical Materials and Engineering, Northwestern Polytechnical University (NPU), 127 West Youyi Road, Xían 710072, P.R. China.

Ermei Mäkilä (E)

Laboratory of Industrial Physics, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland.

Jarno Salonen (J)

Laboratory of Industrial Physics, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland.

Jouni T Hirvonen (JT)

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.

Yueqi Zhu (Y)

Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Yishan Road, Shanghai 200233, P.R. China.

Yingsheng Cheng (Y)

Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Yishan Road, Shanghai 200233, P.R. China.

Lianfu Deng (L)

Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, P.R. China.

Hongbo Zhang (H)

Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, P.R. China; Pharmaceutical Sciences Laboratory, Åbo Akademi University; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland. Electronic address: hongbo.zhang@abo.fi.

Alexander Kros (A)

Leiden Institute of Chemistry, Leiden University, P.O. Box 9052, 2300 RA Leiden, the Netherlands.

Wenguo Cui (W)

Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, P.R. China. Electronic address: wgcui80@hotmail.com.

Hélder A Santos (HA)

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, 00014 Helsinki, Finland. Electronic address: helder.santos@helsinki.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH